CERE (Cerevel Therapeutics) Earnings per share growth rate in current year

Corporate emblem and logo of Cerevel Corp (CERE)

The financial foundation of Cerevel Therapeutics (CERE) relies on the development of neuropreparations for clinics and insurance companies. The annual growth rate of net income per share demonstrates the current status of 0.00, reflecting the market consensus. Capital stability is supported by patent protection and alliances with industry behemoths, while business security is guaranteed by operating within US jurisdiction outside the scope of trade conflicts.

CERE: Cerevel Therapeutics Inc Net earnings per share growth this year 07/04/2022 - 08/10/2024

Financial and market metric breakdowns for Cerevel Therapeutics, Inc. (CERE)

- share price and consensus valuation forecast:
Fundamental valuation:CERE Cerevel Corp
Flagship merchandise of cerevel.com

Cerevel Therapeutics (CERE) specializes in developing treatments for neurological disorders, mitigating the sector's binary risks through integration into a pharma behemoth's structure. This indicator digitizes net earnings per share dynamics, reflecting the efficiency of clinical pipeline capitalization relative to the previous year. Analyzing the annual EPS range allows for the timely detection of margin compression and prevents capital from being frozen in weakening assets.

Main competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Earnings per share growth this year CRGT|Net earnings per share growth this year ATXI|Net earnings per share growth this year Brainstorm Cell (BCLI)|Net earnings per share growth this year CARA (Cara Therapeutics, Inc.)|Net earnings per share growth this year Chromocell Therapeutics Corp CHRO|Earnings growth in current year ELYM (Eliem Therapeutics, Inc.)|Earnings growth in current year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth in current year|Expected net earnings per share growth this year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth in current year|NeuroBo Pharmaceuticals Inc - Earnings per share increase in current year|SAGE (Sage Therapeutics Inc.) - Earnings growth in current year|Earnings per share growth this year SNPX (Neurotrope)|Earnings per share growth in current year Trevena Inc. (TRVN)|VIGL - Earnings per share growth rate in current year|Anew Medical Inc. - Net earnings per share growth this year